A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Clinical trial NCT05710848 · RECRUITING

Trial details

NCT number: NCT05710848
Sponsor: SURGE Therapeutics
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-muscle-invasive Bladder Cancer

Start date: 2023-07-11
Primary completion: 2026-05-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.